Product
Exogenous LEAP2
1 clinical trial
1 indication
Indication
ObesityClinical trial
Effects of Antagonizing the Ghrelin Receptor on Total-body Glucose Metabolism in ObesityStatus: Recruiting, Estimated PCD: 2024-08-01
1 clinical trial
1 indication